Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Title
Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
Publication Date
2019-03-01
Author(s)
Shen, Ting
You, Yuyi
Arunachalam, Sukanya
Fontes, Ariadna
Liu, Sidong
Gupta, Vivek
Parratt, John
Wang, Chenyu
Barnett, Michael
Barton, Joshua
Chitranshi, Nitin
( author )
OrcID: https://orcid.org/0000-0002-6508-9865
Email: nchitran@une.edu.au
UNE Id une-id:nchitran
Zhu, Ling
Fraser, Clare L
Graham, Stuart L
Klistorner, Alexander
Yiannikas, Con
Type of document
Journal Article
Language
en
Entity Type
Publication
Publisher
Elsevier Inc
Place of publication
United States of America
DOI
10.1016/j.ophtha.2018.06.022
UNE publication id
une:1959.11/71682
Abstract

Purpose: To assess differential patterns of axonal loss and demyelination in the optic nerve in multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD).

Design: Cross-sectional study.

Participants: One hundred ninety-two participants, including 136 MS patients (272 eyes), 19 NMOSD patients (38 eyes), and 37 healthy control participants (74 eyes).

atients (38 eyes), and 37 healthy control participants (74 eyes). Methods: All participants underwent spectral-domain OCT scans and multifocal visual evoked potential (mfVEP) recordings. High-resolution magnetic resonance imaging (MRI) with the diffusion protocol also was performed in all patients.

Main Outcome Measures: Ganglion celleinner plexiform layer (GCIPL) thickness and mfVEP amplitude and latency at 5 eccentricities; global and temporal retinal nerve fiber layer thickness.

Results: In optic neuritis (ON) eyes, the NMOSD patients had more severe GCIPL loss (P < 0.001) and mfVEP amplitude reduction (P < 0.001) compared with MS patients, whereas in contrast, mfVEP latency delay was more evident in MS patients (P < 0.001). The NMOSD patients showed more morphologic and functional loss at the foveal to parafoveal region, whereas the MS patients showed evenly distributed damage at the macula. Correlation analysis demonstrated a strong structureefunction (OCTemfVEP) association in the NMOSD patients, which was only moderate in the MS patients. In non-ON (NON) eyes, the MS patients showed significantly thinner GCIPL than controls (P < 0.001), whereas no GCIPL loss was observed in NON eyes in NMOSD. In addition, a significant correlation was found between all OCT and mfVEP measures in MS patients, but not in NMOSD patients. MRI demonstrated significant lesional load in the optic radiation in MS compared to NMOSD eyes (P = 0.002), which was related to the above OCT and mfVEP changes in NON eyes.

Conclusions: Our study demonstrated different patterns of ON damage in NMOSD and MS. In MS, the ON damage was less severe, with demyelination as the main pathologic component, whereas in NMOSD, axonal loss was more severe compared with myelin loss. The disproportional mfVEP amplitude and latency changes suggested predominant axonal damage within the anterior visual pathway as the main clinical feature of NMOSD, in contrast to MS, where demyelination spreads along the entire visual pathway.

Link
Citation
Ophthalmology, 126(3), p. 445-453
ISSN
1549-4713
0161-6420
Start page
445
End page
453

Files:

NameSizeformatDescriptionLink